IMS Health Hungary

Last updated: 24.05.2016

IMS Health Logo

Since its establishment in 1991, IMS Health Hungary has achieved the position of a trusted advisor and leader in providing insights into the pharmaceutical market. IMS Health Hungary has one of the most comprehensive offering portfolios in the region, with solutions for the life sciences industry including prescription data, sell-out services and patient level analytics.

In 2008, IMS Health Hungary made a significant investment to deliver more accurate data for measuring final drug consumption levels and introduced a sell-out offering.

Since 2013, as a result of further developments in the utilization of longitudinal patient level data, IMS Health Hungary has supported clients with a deep understanding of patient dynamics to identify appropriate patient segments and tailor strategic decisions. Anonymized longitudinal patient level information provides a powerful patient lens to drive focus and alignment across business; deepening the understanding of critical patient, physician and payer dynamics.

For over two decades IMS Health Hungary has been monitoring the changes and development of the national market. In 2012, the Hungarian pharmaceutical market reached €2.1 billion (retail and hospital), contracting by close to 3 %, as a result of austerity measures. Currently 412 manufacturer groups operate in the Hungarian pharmaceutical market, with 10 corporations, including the two largest local manufacturers EGIS and Gedeon Richter, accounting for 56% of the total sales value. Generics are dominating the market with close to a 60% share of volume in 2012, while original products still hold 53% of the pharmaceutical market in value. The top therapy areas in 2012 were antineoplastic and cardiovascular.

Contact

IMS Health Hungary
Rumbach Sebestyén utca 19-21.
Budapest 1075, Hungary
Tel: +36 1 883 9700
Fax: +36 1 883 9799

Interviews

Related

We use cookies to ensure that we give you the best experience on our site. For more info click here